About Corstasis Therapeutics
Corstasis Therapeutics is a company based in Henderson (United States) founded in 2018 by Benjamin Esque was acquired by Esperion Therapeutics in March 2026.. Corstasis Therapeutics offers products and services including Outpatient Therapeutic Options and Therapeutic Pipeline. Corstasis Therapeutics operates in a competitive market with competitors including NGM Biopharmaceuticals, AskBio, Nimbus Therapeutics, Altimmune and Mirum Pharmaceuticals, among others.
- Headquarter Henderson, United States
- Founders Benjamin Esque
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Corstasis Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Esperion Therapeutics
(Mar 03, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Corstasis Therapeutics
Corstasis Therapeutics offers a comprehensive portfolio of products and services, including Outpatient Therapeutic Options and Therapeutic Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Home-based solutions for fluid overload in heart and organ diseases.
Innovative treatments for kidney and liver conditions via outpatient methods.
Funding Insights of Corstasis Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Corstasis Therapeutics
Corstasis Therapeutics has secured backing from 1 investor. Prominent investors backing the company include Esperion Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Corstasis Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Corstasis Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Corstasis Therapeutics Comparisons
Competitors of Corstasis Therapeutics
Corstasis Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NGM Biopharmaceuticals, AskBio, Nimbus Therapeutics, Altimmune and Mirum Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biologics are developed for cardio-metabolic and liver diseases.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics are developed for rare diseases treatment.
|
|
| domain | founded_year | HQ Location |
Develops small molecule drugs for the treatment of cardiovascular and metabolic diseases and non-alcoholic steatohepatitis
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Corstasis Therapeutics
Frequently Asked Questions about Corstasis Therapeutics
When was Corstasis Therapeutics founded?
Corstasis Therapeutics was founded in 2018.
Where is Corstasis Therapeutics located?
Corstasis Therapeutics is headquartered in Henderson, United States. It is registered at Henderson, Nevada, United States.
Who is the current CEO of Corstasis Therapeutics?
Benjamin Esque is the current CEO of Corstasis Therapeutics. They have also founded this company.
What does Corstasis Therapeutics do?
Corstasis Therapeutics was founded in 2018 and is located in Henderson, United States. Focus is placed on developing therapeutics to address fluid volume overload, especially in congestive heart failure, liver disease, and kidney disease. The pipeline includes RSQ-777 as an intranasal diuretic, RSQ-786 as a sublingual diuretic, and RSQ-789 as a subcutaneous diuretic. Operations center on advancing these candidates through clinical stages in the biotechnology sector.
Who are the top competitors of Corstasis Therapeutics?
Corstasis Therapeutics's top competitors include Nimbus Therapeutics, AskBio and NGM Biopharmaceuticals.
What products or services does Corstasis Therapeutics offer?
Corstasis Therapeutics offers Outpatient Therapeutic Options and Therapeutic Pipeline.
Who are Corstasis Therapeutics's investors?
Corstasis Therapeutics has 1 investor. Key investors include Esperion Therapeutics.